Hopefully not, I'd rather see Nova Eye reach its full potential rather than be acquired so early in its journey.
Nonetheless, there has been lots of M&A in the MIGS space recently, with one last year for a pre-revenue MIGS manufacturer that won't receive FDA approval for years fetching a price tag 15x higher than the current market cap of EYE (which is already revenue generating, and as of a few weeks ago FDA approved). Nova Eye certainly looks very cheap relative to recent comps (and therefore very appealing to big pharma/PE)
Ann: FDA Clears iTrack Advance for US Launch, page-46
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
-0.005(2.13%) |
Mkt cap ! $52.62M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.0¢ | 23.0¢ | $103.1K | 445.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1700 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 100000 | 2 |
View Market Depth
| Last trade - 14.39pm 04/06/2024 (20 minute delay) ? |
|
|||||
|
Last
23.5¢ |
Change
-0.005 ( 2.08 %) |
||||
| Open | High | Low | Volume | ||
| 24.0¢ | 24.0¢ | 23.0¢ | 324599 | ||
| Last updated 15.52pm 04/06/2024 ? | |||||
| EYE (ASX) Chart |